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Items for this week’s EPI Update include: 
 Mumps activity continuing 
 2014-2015 influenza vaccine effectiveness in hospitalized adults 
 Recent public health achievements – vaccine preventable diseases 
 Meeting announcements and training opportunities 
 
Mumps activity continuing  
Mumps cases continue to occur on the University of Iowa campus. Since the incubation 
period for mumps can be up to 21 days, it is too early for the vaccine campaign to have 
significantly impacted case counts. The vaccination campaign (with the 
recommendation to administer a 3rd dose of MMR to University of Iowa students less 
than 25 years of age) continues and the number of new cases will continue to be closely 
monitored over the next several weeks at least.  
 
2014-2015 influenza vaccine effectiveness in hospitalized adults 
During the 2014-2015 influenza season, the circulating influenza A (H3N2) virus drifted, 
causing a partial mismatch between the vaccine and circulating strains.  
 
A new study out of Michigan looked at the vaccine effectiveness against influenza 
hospitalizations during the 2014-2015 influenza season. The study looked at adults 
hospitalized for acute respiratory illness at two Michigan hospitals and found that the 
adjusted vaccine effectiveness was estimated at 45 percent against influenza A (H3N2); 
higher than what is being reported from studies done in ambulatory care settings. This 
study may indicate that the vaccine was more effective in preventing severe cases of 
influenza requiring hospitalization, than in preventing illness resulting in ambulatory 
care. For more information, visit 
idsa.confex.com/idsa/2015/webprogram/Paper54084.html.  
 
Recent public health achievements – vaccine preventable diseases 
During December, some of the more notable recent public health achievements will be 
highlighted.   
 
The past decade has seen substantial declines in cases, hospitalizations, deaths, and 
health-care costs associated with vaccine-preventable diseases. This has been 
achieved by the use of new vaccines (i.e., rotavirus, quadrivalent meningococcal 
conjugate, varicella/shingles, pneumococcal conjugate, and human papillomavirus 
vaccines), use of vaccines for new populations (such as tetanus, diphtheria, and 
acellular pertussis vaccine for adults and adolescents), and improving vaccination 
rates. Today, 17 diseases are targeted by U.S. immunization policy. A recent economic 
analysis indicated that vaccination of each U.S. birth cohort with the current childhood 
immunization schedule prevents approximately 42,000 deaths and 20 million cases of 
disease, with net savings of nearly $14 billion in direct costs and $69 billion in total 
societal costs. For more information, visit; 
www.cdc.gov/mmwr/preview/mmwrhtml/mm6019a5.htm.  
 
IDPH would like to thanks all our immunization partners for their past and continued 
hard work protecting the health of all Iowans. 
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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